SCHEMBL10353035

SCHEMBL10353035

N#Cc1ccc(Oc2cccc(Oc3cccc(Oc4cccc(Oc5ccc(C#N)c(C#N)c5)n4)c3)n2)cc1C#N

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 2/20 0.56
▸ ALDH1A1 P00352 5/20 0.54
▸ HPGD P15428 2/20 0.54
▸ F2 P00734 3/20 0.47
▸ F10 P00742 3/20 0.47
▸ MAOB P27338 3/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ AR P10275 3/20 0.43
▸ MAOA P21397 2/20 0.42
▸ MAP4K4 O95819 1/20 0.42
▸ POLB P06746 1/20 0.40
▸ PDE4B Q07343 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ RXFP1 Q9HBX9 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ THRB P10828 1/20 0.40
▸ PRSS1 P07477 1/20 0.39
▸ PRSS2 P07478 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10352210 0.97 ALDH1A1 (0.56) CYP19A1ALDH1A1HPGDF2F10
SCHEMBL10352809 0.87 CYP19A1 (0.54) CYP19A1ALDH1A1HPGDF2F10
SCHEMBL31168160 0.86 CYP19A1 (0.67) CYP19A1ALDH1A1HPGDMAOBNPSR1
SCHEMBL5145150 0.86 CYP19A1 (0.67) CYP19A1ALDH1A1HPGDMAOBNPSR1
SCHEMBL1374021 0.86 CYP19A1 (0.67) CYP19A1ALDH1A1HPGDMAOBNPSR1
SCHEMBL10352215 0.85 CYP19A1 (0.47) CYP19A1ALDH1A1HPGDF2F10
SCHEMBL9745656 0.84 ALDH1A1 (0.61) CYP19A1ALDH1A1HPGDMAOBNPSR1
SCHEMBL5143806 0.84 ALDH1A1 (0.61) CYP19A1ALDH1A1HPGDMAOBNPSR1
SCHEMBL9746267 0.84 ALDH1A1 (0.61) CYP19A1ALDH1A1HPGDMAOBNPSR1
SCHEMBL9746946 0.84 ALDH1A1 (0.61) CYP19A1ALDH1A1HPGDMAOBNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362239-B2 Heteroaromatic phthalonitriles THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2013-01-29 — — US disclosed
US-20120232270-A1 HETEROAROMATIC PHTHALONITRILES THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2012-09-13 — — US disclosed
US-8222403-B2 Heteroaromatic phthalonitriles THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2012-07-17 — — US disclosed
US-20110108755-A1 HETEROAROMATIC PHTHALONITRILES THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2011-05-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120232270-A1 HETEROAROMATIC PHTHALONITRILES ARNT, PBRM1, NR4A1 CYP19A1 1685/4885ALDH1A1 1493/4885HPGD 1536/4885
US-20110108755-A1 HETEROAROMATIC PHTHALONITRILES ARNT, PBRM1, NR4A1 CYP19A1 1685/4885ALDH1A1 1493/4885HPGD 1536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback